Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial

Description: Randomized, double-blind, placebo-controlled, cross-over design to compare the impacts of a single intranasal oxytocin dose on amygdala connectivity among individuals with schizophrenia (n = 22) versus healthy controls (n = 24).

Related article: http://doi.org/10.1093/schbul/sbz091

View ID Name Type
Field Value
Compact Identifierhttps://identifiers.org/neurovault.collection:5488
Add DateJune 5, 2019, 9:28 p.m.
Uploaded bysvabram
Related article DOI10.1093/schbul/sbz091
Related article authorsSamantha V Abram, Lize De Coster, Brian J Roach, Bryon A Mueller, Theo G M van Erp, Vince D Calhoun, Adrian Preda, Kelvin O Lim, Jessica A Turner, Judith M Ford, Daniel H Mathalon and Joshua D Woolley
Citation guidelines

If you use the data from this collection please include the following persistent identifier in the text of your manuscript:


This will help to track the use of this data in the literature. In addition, consider also citing the paper related to this collection.